.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Argus Health
Cipla
Daiichi Sankyo
Boehringer Ingelheim
Fish and Richardson
Fuji
Cantor Fitzgerald
McKesson
Merck

Generated: December 14, 2017

DrugPatentWatch Database Preview

Enoxaparin sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for enoxaparin sodium and what is the scope of enoxaparin sodium freedom to operate?

Enoxaparin sodium
is the generic ingredient in four branded drugs marketed by Sandoz Inc, Sanofi Aventis Us, Amphastar Pharm, Sandoz, and Teva, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for enoxaparin sodium. Nine suppliers are listed for this compound.

Pharmacology for enoxaparin sodium

Medical Subject Heading (MeSH) Categories for enoxaparin sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
SandozENOXAPARIN SODIUM (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS077857-004Jul 23, 2010APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaENOXAPARIN SODIUM (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS076726-001Jun 23, 2014APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaENOXAPARIN SODIUM (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS076726-002Jun 23, 2014APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozENOXAPARIN SODIUM (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS077857-005Jul 23, 2010APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaENOXAPARIN SODIUM (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS076726-004Jun 23, 2014APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Amphastar PharmENOXAPARIN SODIUM (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS076684-001Sep 19, 2011APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Amphastar PharmENOXAPARIN SODIUM (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS076684-002Sep 19, 2011APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sanofi Aventis UsLOVENOX (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS020164-008Jun 2, 2000APRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaENOXAPARIN SODIUM (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS076726-003Jun 23, 2014APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Amphastar PharmENOXAPARIN SODIUM (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS076684-006Sep 19, 2011APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: enoxaparin sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis UsLOVENOX (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS020164-004Mar 27, 1998► Subscribe► Subscribe
Sanofi Aventis UsLOVENOX (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS020164-004Mar 27, 1998► Subscribe► Subscribe
Sanofi Aventis UsLOVENOX (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS020164-001Mar 29, 1993► Subscribe► Subscribe
Sanofi Aventis UsLOVENOX (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS020164-006Jun 2, 2000► Subscribe► Subscribe
Sanofi Aventis UsLOVENOX (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS020164-008Jun 2, 2000► Subscribe► Subscribe
Sanofi Aventis UsLOVENOX (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS020164-003Mar 27, 1998► Subscribe► Subscribe
Sanofi Aventis UsLOVENOX (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS020164-008Jun 2, 2000► Subscribe► Subscribe
Sanofi Aventis UsLOVENOX (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS020164-008Jun 2, 2000► Subscribe► Subscribe
Sanofi Aventis UsLOVENOX (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS020164-003Mar 27, 1998► Subscribe► Subscribe
Sanofi Aventis UsLOVENOXenoxaparin sodiumINJECTABLE;INTRAVENOUS, SUBCUTANEOUS020164-009Jan 23, 2003► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Cantor Fitzgerald
Covington
Baxter
Novartis
Chinese Patent Office
Dow
Cerilliant
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot